- $522.38m
- $1.01bn
- $160.95m
- 38
- 28
- 28
- 22
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 17.5 | 14.6 | 22.2 | 54.6 | 161 |
Cost of Revenue | |||||
Gross Profit | -8.75 | -12.6 | -6.83 | -5.65 | 9.71 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 52.5 | 73.8 | 112 | 204 | 314 |
Operating Profit | -34.9 | -59.2 | -89.8 | -150 | -153 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -24.8 | -48.2 | -57.8 | -106 | -135 |
Provision for Income Taxes | |||||
Net Income After Taxes | -24.8 | -48.2 | -57.8 | -106 | -135 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -24.8 | -48.2 | -5.91 | -27.6 | -42.4 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -24.8 | -48.2 | -5.91 | -27.3 | -42.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.094 | -0.182 | -0.087 | -0.319 | -0.3 |